These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
434 related articles for article (PubMed ID: 15884237)
1. [Value of the photodynamic method in the diagnosis of superficial bladder tumors]. Lipiński MI; Jeromin LM Wiad Lek; 2004; 57 Suppl 1():192-5. PubMed ID: 15884237 [TBL] [Abstract][Full Text] [Related]
2. Hexylaminolaevulinate 'blue light' fluorescence cystoscopy in the investigation of clinically unconfirmed positive urine cytology. Ray ER; Chatterton K; Khan MS; Thomas K; Chandra A; O'Brien TS BJU Int; 2009 May; 103(10):1363-7. PubMed ID: 19076151 [TBL] [Abstract][Full Text] [Related]
3. Seven years' experience with 5-aminolevulinic acid in detection of transitional cell carcinoma of the bladder. Hungerhuber E; Stepp H; Kriegmair M; Stief C; Hofstetter A; Hartmann A; Knuechel R; Karl A; Tritschler S; Zaak D Urology; 2007 Feb; 69(2):260-4. PubMed ID: 17320660 [TBL] [Abstract][Full Text] [Related]
4. Oral 5-aminolevulinic acid in simultaneous photodynamic diagnosis of upper and lower urinary tract transitional cell carcinoma - a prospective audit. Ahmad S; Aboumarzouk O; Somani B; Nabi G; Kata SG BJU Int; 2012 Dec; 110(11 Pt B):E596-600. PubMed ID: 22758907 [TBL] [Abstract][Full Text] [Related]
5. Fluorescence-guided transurethral resection of bladder tumours reduces bladder tumour recurrence due to less residual tumour tissue in Ta/T1 patients: a randomized two-centre study. Hermann GG; Mogensen K; Carlsson S; Marcussen N; Duun S BJU Int; 2011 Oct; 108(8 Pt 2):E297-303. PubMed ID: 21414125 [TBL] [Abstract][Full Text] [Related]
6. Photodynamic diagnostics and noninvasive bladder cancer: is it cost-effective in long-term application? A Germany-based cost analysis. Burger M; Zaak D; Stief CG; Filbeck T; Wieland WF; Roessler W; Denzinger S Eur Urol; 2007 Jul; 52(1):142-7. PubMed ID: 17267099 [TBL] [Abstract][Full Text] [Related]
7. [Hexaminolevulinate photodynamic diagnosis in non-muscle invasive bladder cancer: experience of the BLUE group]. Burgués JP; Conde G; Oliva J; Abascal JM; Iborra I; Puertas M; Ordoño F; Actas Urol Esp; 2011 Sep; 35(8):439-45. PubMed ID: 21621301 [TBL] [Abstract][Full Text] [Related]
8. Is photodynamic diagnosis using hypericin better than white-light cystoscopy for detecting superficial bladder carcinoma? Sim HG; Lau WK; Olivo M; Tan PH; Cheng CW BJU Int; 2005 Jun; 95(9):1215-8. PubMed ID: 15892804 [TBL] [Abstract][Full Text] [Related]
9. Transurethral resection of non-muscle-invasive bladder transitional cell cancers with or without 5-aminolevulinic Acid under visible and fluorescent light: results of a prospective, randomised, multicentre study. Schumacher MC; Holmäng S; Davidsson T; Friedrich B; Pedersen J; Wiklund NP Eur Urol; 2010 Feb; 57(2):293-9. PubMed ID: 19913351 [TBL] [Abstract][Full Text] [Related]
10. Clinically relevant improvement of recurrence-free survival with 5-aminolevulinic acid induced fluorescence diagnosis in patients with superficial bladder tumors. Filbeck T; Pichlmeier U; Knuechel R; Wieland WF; Roessler W J Urol; 2002 Jul; 168(1):67-71. PubMed ID: 12050494 [TBL] [Abstract][Full Text] [Related]
11. 5-aminolaevulinic acid-induced fluorescence cystoscopy during transurethral resection reduces the risk of recurrence in stage Ta/T1 bladder cancer. Babjuk M; Soukup V; Petrík R; Jirsa M; Dvorácek J BJU Int; 2005 Oct; 96(6):798-802. PubMed ID: 16153204 [TBL] [Abstract][Full Text] [Related]
12. Hexaminolevulinate is equal to 5-aminolevulinic acid concerning residual tumor and recurrence rate following photodynamic diagnostic assisted transurethral resection of bladder tumors. Burger M; Stief CG; Zaak D; Stenzl A; Wieland WF; Jocham D; Otto W; Denzinger S Urology; 2009 Dec; 74(6):1282-6. PubMed ID: 19819538 [TBL] [Abstract][Full Text] [Related]
13. Does photodynamic transurethral resection of bladder tumour improve the outcome of initial T1 high-grade bladder cancer? A long-term follow-up of a randomized study. Denzinger S; Wieland WF; Otto W; Filbeck T; Knuechel R; Burger M BJU Int; 2008 Mar; 101(5):566-9. PubMed ID: 17986289 [TBL] [Abstract][Full Text] [Related]
14. [Role of fluorescent control in raising radicality of surgical treatment for superficial bladder cancer]. Matveev BP; Kudashev BV; Bukharkin BV; Romanov VA; Rubanov IuV Urologiia; 2000; (3):22-4. PubMed ID: 11186703 [TBL] [Abstract][Full Text] [Related]
15. Clinically relevant reduction in risk of recurrence of superficial bladder cancer using 5-aminolevulinic acid-induced fluorescence diagnosis: 8-year results of prospective randomized study. Denzinger S; Burger M; Walter B; Knuechel R; Roessler W; Wieland WF; Filbeck T Urology; 2007 Apr; 69(4):675-9. PubMed ID: 17445650 [TBL] [Abstract][Full Text] [Related]
16. [Fluorescence diagnosis in patients with non-muscle invasive bladder cancer: results of a metaanalysis]. Kausch I; Sommerauer M; Montorsi F; Stenzl A; Jacqmin D; Jichlinski P; Jocham D; Ziegler A; Vonthein R Aktuelle Urol; 2010 May; 41(3):171-7. PubMed ID: 20486035 [TBL] [Abstract][Full Text] [Related]